4/3
08:04 am
neo
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) [Yahoo! Finance]
Low
Report
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) [Yahoo! Finance]
4/1
07:05 am
neo
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
Low
Report
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
3/21
09:41 am
neo
3 Reasons to Sell NEO and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Sell NEO and 1 Stock to Buy Instead [Yahoo! Finance]
3/18
07:05 am
neo
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
Medium
Report
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
3/10
07:00 am
neo
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
Medium
Report
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
2/26
01:31 pm
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Piper Sandler from $21.00 to $18.00. They now have an "overweight" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Piper Sandler from $21.00 to $18.00. They now have an "overweight" rating on the stock.
2/24
07:05 am
neo
NeoGenomics to Participate in Upcoming Investor Conferences
Low
Report
NeoGenomics to Participate in Upcoming Investor Conferences
2/19
08:19 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Bank of America Co. from $19.00 to $16.00. They now have a "neutral" rating on the stock.
Medium
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Bank of America Co. from $19.00 to $16.00. They now have a "neutral" rating on the stock.
2/19
08:00 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Needham & Company LLC from $19.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Needham & Company LLC from $19.00 to $18.00. They now have a "buy" rating on the stock.
2/18
12:32 pm
neo
NeoGenomics, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
High
Report
NeoGenomics, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/18
12:25 pm
neo
NeoGenomics targets 1M patients annually by 2028 with 11%-13% revenue growth in 2025 [Seeking Alpha]
High
Report
NeoGenomics targets 1M patients annually by 2028 with 11%-13% revenue growth in 2025 [Seeking Alpha]
2/18
12:03 pm
neo
NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance [Seeking Alpha]
High
Report
NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance [Seeking Alpha]
2/18
07:48 am
neo
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets [Yahoo! Finance]
Medium
Report
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets [Yahoo! Finance]
2/18
07:28 am
neo
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results [Yahoo! Finance]
Medium
Report
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results [Yahoo! Finance]
2/18
07:10 am
neo
NeoGenomics reports mixed Q4 earnings; reaffirms FY25 outlook [Seeking Alpha]
Medium
Report
NeoGenomics reports mixed Q4 earnings; reaffirms FY25 outlook [Seeking Alpha]
2/18
07:05 am
neo
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
High
Report
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
2/17
08:36 am
neo
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect [Yahoo! Finance]
High
Report
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect [Yahoo! Finance]
2/7
12:13 pm
neo
Immunodiagnostics Market Size Expected to Reach USD 70.9 Bn by 2034 [Yahoo! Finance]
Low
Report
Immunodiagnostics Market Size Expected to Reach USD 70.9 Bn by 2034 [Yahoo! Finance]
2/3
09:36 am
neo
At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors [Yahoo! Finance]
Low
Report
At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors [Yahoo! Finance]
1/29
08:23 am
neo
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 [Yahoo! Finance]
Medium
Report
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 [Yahoo! Finance]
1/29
08:05 am
neo
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
Medium
Report
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
1/28
11:06 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $20.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $20.00 to $18.00. They now have a "buy" rating on the stock.
1/15
08:55 am
neo
NeoGenomics rises on upbeat sales outlook for 2025 [Seeking Alpha]
Low
Report
NeoGenomics rises on upbeat sales outlook for 2025 [Seeking Alpha]
1/15
07:47 am
neo
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan [Yahoo! Finance]
Low
Report
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan [Yahoo! Finance]
1/15
07:05 am
neo
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
Medium
Report
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan